Plus Therapeutics (PSTV) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
31 Mar, 2026Voting matters and shareholder proposals
Election of six directors for a one-year term, with nominees listed for shareholder approval.
Ratification of CBIZ P.C. as the independent registered public accounting firm for the 2026 fiscal year.
Advisory vote on executive compensation for named executive officers.
Approval of the Sixth Amendment and Restatement of the 2020 Stock Incentive Plan.
Additional business may be transacted as properly brought before the meeting.
Board of directors and corporate governance
Six director nominees are presented for election, each to serve until the 2027 annual meeting or until a successor is elected.
Executive compensation and say-on-pay
Shareholders are asked to provide a non-binding advisory vote on the compensation of named executive officers.
Proposal includes approval of amendments to the 2020 Stock Incentive Plan.
Latest events from Plus Therapeutics
- $15M raise funds pivotal trials, CNSide scale-up, and 2026 commercial expansion.PSTV
Business update9 Jul 2026 - $15M financing and clinical progress support CNSide's 2025 launch and CNS cancer milestones.PSTV
Q4 20248 Jul 2026 - Cerenome rebrands and advances CNS oncology with integrated therapeutics, diagnostics, and AI.PSTV
Investor update1 Jul 2026 - Shelf registration allows flexible securities offerings; Canaccord Genuity LLC is distribution agent.PSTV
Registration filing5 Jun 2026 - At-the-market equity offering of up to $17.35M targets CNS cancer innovation, with dilution risk.PSTV
Registration filing2 Jun 2026 - 186RNL shows safety, efficacy, and immune activation in leptomeningeal metastases.PSTV
2026 AANS Annual Scientific Meeting presentation22 May 2026 - Net loss narrowed, cash and investments rose, and funding remains critical amid clinical and commercial progress.PSTV
Q1 202615 May 2026 - All proposals, including board election and stock plan amendment, were approved by shareholders.PSTV
AGM 202614 May 2026 - Board seeks approval for director elections, auditor ratification, and expanded equity plan.PSTV
Proxy filing31 Mar 2026